Article
Simulation-driven design of stabilized SARS-CoV-2 spike S2 immunogens
27 Aug 2024
Abstract excerpt
The full-length prefusion-stabilized SARS-CoV-2 spike (S) is the principal antigen of COVID-19 vaccines. Vaccine efficacy has been impacted by emerging variants of concern that accumulate most of the sequence modifications in the immunodominant S1 subunit. S2, in contrast, is the most evolutionarily conserved region of the spike and can elicit broadly neutralizing and protective antibodies. Yet, S2's usage as an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
